Evommune is a clinical-stage biotechnology company discovering and developing innovative therapies that target key drivers of chronic inflammatory diseases
Evommune is a clinical-stage biotechnology company discovering and developing innovative therapies that target key drivers of chronic inflammatory diseases. The company's mission is to improve patients' daily lives and prevent the long-term effects of uncontrolled inflammation that are a consequence of the limitations of existing therapies.